TY - JOUR AU - El-Serag, H. B. AU - Sweet, S. AU - Winchester, C. C. AU - Dent, J. PY - 2014 DA - 2014// TI - Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review JO - Gut VL - 63 UR - https://doi.org/10.1136/gutjnl-2012-304269 DO - 10.1136/gutjnl-2012-304269 ID - El-Serag2014 ER - TY - JOUR AU - Sigterman, K. E. AU - van Pinxteren, B. AU - Bonis, P. A. AU - Lau, J. AU - Numans, M. E. PY - 2013 DA - 2013// TI - Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease JO - Cochrane Database Syst Rev VL - 5 ID - Sigterman2013 ER - TY - STD TI - Hunt R, Quigley E, Abbas Z, Eliakim A, Emmanuel A, Goh KL, et al. Coping with common gastrointestinal symptoms in the community: a global perspective on heartburn, constipation, bloating, and abdominal pain/discomfort May 2013. J Clin Gastroenterol. 2014;48(7):567–78. ID - ref3 ER - TY - JOUR AU - Boardman, H. F. AU - Heeley, G. PY - 2015 DA - 2015// TI - The role of the pharmacist in the selection and use of over-the-counter proton-pump inhibitors JO - Int J Clin Pharm VL - 37 UR - https://doi.org/10.1007/s11096-015-0150-z DO - 10.1007/s11096-015-0150-z ID - Boardman2015 ER - TY - STD TI - Nexium 24HR [product labeling]. Madison, NJ: Pfizer Consumer Healthcare; 2014. ID - ref5 ER - TY - JOUR AU - Peura, D. A. AU - Traxler, B. AU - Kocun, C. AU - Lind, T. PY - 2014 DA - 2014// TI - Esomeprazole treatment of frequent heartburn: two randomized, double-blind, placebo-controlled trials JO - Postgrad Med VL - 126 UR - https://doi.org/10.3810/pgm.2014.07.2781 DO - 10.3810/pgm.2014.07.2781 ID - Peura2014 ER - TY - JOUR AU - Hunfeld, N. G. AU - Geus, W. P. AU - Kuipers, E. J. PY - 2007 DA - 2007// TI - Systematic review: rebound acid hypersecretion after therapy with proton pump inhibitors JO - Aliment Pharmacol Ther VL - 25 UR - https://doi.org/10.1111/j.1365-2036.2006.03171.x DO - 10.1111/j.1365-2036.2006.03171.x ID - Hunfeld2007 ER - TY - JOUR AU - Haastrup, P. AU - Paulsen, M. S. AU - Begtrup, L. M. AU - Hansen, J. M. AU - Jarbol, D. E. PY - 2014 DA - 2014// TI - Strategies for discontinuation of proton pump inhibitors: a systematic review JO - Fam Pract VL - 31 UR - https://doi.org/10.1093/fampra/cmu050 DO - 10.1093/fampra/cmu050 ID - Haastrup2014 ER - TY - JOUR AU - Kushner, P. R. AU - Snoddy, A. M. AU - Gilderman, L. AU - Peura, D. A. PY - 2009 DA - 2009// TI - Lansoprazole 15 mg once daily for 14 days is effective for treatment of frequent heartburn: results of 2 randomized, placebo-controlled, double-blind studies JO - Postgrad Med VL - 121 UR - https://doi.org/10.3810/pgm.2009.07.2019 DO - 10.3810/pgm.2009.07.2019 ID - Kushner2009 ER - TY - JOUR AU - Peura, D. AU - Le Moigne, A. AU - Pollack, C. AU - Nagy, P. AU - Lind, T. PY - 2016 DA - 2016// TI - A 14-day regimen of esomeprazole 20 mg/day for frequent heartburn: durability of effects, symptomatic rebound, and treatment satisfaction JO - Postgrad Med VL - 128 UR - https://doi.org/10.1080/00325481.2016.1203236 DO - 10.1080/00325481.2016.1203236 ID - Peura2016 ER - TY - STD TI - Johnson DA, Le Moigne A, Li J, Pollack C, Nagy P. Analysis of clinical predictors of resolution of sleep disturbance related to frequent nighttime heartburn and acid regurgitation symptoms in individuals taking esomeprazole 20 mg or placebo. Clin Drug Investig. 2016;36(7):531–8. ID - ref11 ER - TY - STD TI - Bardhan KD, Muller-Lissner S, Bigard MA, Bianchi PG, Ponce J, Hosie J, et al. Symptomatic gastro-oesophageal reflux disease: double blind controlled study of intermittent treatment with omeprazole or ranitidine. The European Study Group. BMJ. 1999;318(7182):502–7. ID - ref12 ER - TY - JOUR AU - Ponce, J. AU - Arguello, L. AU - Bastida, G. AU - Ponce, M. AU - Ortiz, V. AU - Garrigues, V. PY - 2004 DA - 2004// TI - On-demand therapy with rabeprazole in nonerosive and erosive gastroesophageal reflux disease in clinical practice: effectiveness, health-related quality of life, and patient satisfaction JO - Dig Dis Sci VL - 49 UR - https://doi.org/10.1023/B:DDAS.0000034551.39324.c3 DO - 10.1023/B:DDAS.0000034551.39324.c3 ID - Ponce2004 ER - TY - JOUR AU - Shin, J. M. AU - Sachs, G. PY - 2008 DA - 2008// TI - Pharmacology of proton pump inhibitors JO - Curr Gastroenterol Rep VL - 10 UR - https://doi.org/10.1007/s11894-008-0098-4 DO - 10.1007/s11894-008-0098-4 ID - Shin2008 ER - TY - JOUR AU - Hassan-Alin, M. AU - Andersson, T. AU - Bredberg, E. AU - Rohss, K. PY - 2000 DA - 2000// TI - Pharmacokinetics of esomeprazole after oral and intravenous administration of single and repeated doses to healthy subjects JO - Eur J Clin Pharmacol VL - 56 UR - https://doi.org/10.1007/s002280000206 DO - 10.1007/s002280000206 ID - Hassan-Alin2000 ER - TY - JOUR AU - Gedda, K. AU - Scott, D. AU - Besancon, M. AU - Lorentzon, P. AU - Sachs, G. PY - 1995 DA - 1995// TI - Turnover of the gastric H+,K(+)-adenosine triphosphatase alpha subunit and its effect on inhibition of rat gastric acid secretion JO - Gastroenterology VL - 109 UR - https://doi.org/10.1016/0016-5085(95)90571-5 DO - 10.1016/0016-5085(95)90571-5 ID - Gedda1995 ER - TY - JOUR AU - Ferron, G. M. AU - McKeand, W. AU - Mayer, P. R. PY - 2001 DA - 2001// TI - Pharmacodynamic modeling of pantoprazole's irreversible effect on gastric acid secretion in humans and rats JO - J Clin Pharmacol VL - 41 UR - https://doi.org/10.1177/00912700122009953 DO - 10.1177/00912700122009953 ID - Ferron2001 ER - TY - JOUR AU - Wallmark, B. AU - Larsson, H. AU - Humble, L. PY - 1985 DA - 1985// TI - The relationship between gastric acid secretion and gastric H+,K+-ATPase activity JO - J Biol Chem VL - 260 ID - Wallmark1985 ER - TY - JOUR AU - Im, W. B. AU - Blakeman, D. P. AU - Davis, J. P. PY - 1985 DA - 1985// TI - Irreversible inactivation of rat gastric (H+-K+)-ATPase in vivo by omeprazole JO - Biochem Biophys Res Commun VL - 126 UR - https://doi.org/10.1016/0006-291X(85)90573-X DO - 10.1016/0006-291X(85)90573-X ID - Im1985 ER - TY - STD TI - Reimer C, Sondergaard B, Hilsted L, Bytzer P. Proton-pump inhibitor therapy induces acid-related symptoms in healthy volunteers after withdrawal of therapy. Gastroenterology. 2009;137(1):80–7. ID - ref20 ER - TY - JOUR AU - Niklasson, A. AU - Lindstrom, L. AU - Simren, M. AU - Lindberg, G. AU - Bjornsson, E. PY - 2010 DA - 2010// TI - Dyspeptic symptom development after discontinuation of a proton pump inhibitor: a double-blind placebo-controlled trial JO - Am J Gastroenterol VL - 105 UR - https://doi.org/10.1038/ajg.2010.81 DO - 10.1038/ajg.2010.81 ID - Niklasson2010 ER - TY - JOUR AU - Juul-Hansen, P. AU - Rydning, A. PY - 2011 DA - 2011// TI - Clinical and pathophysiological consequences of on-demand treatment with PPI in endoscopy-negative reflux disease. Is rebound hypersecretion of acid a problem? JO - Scand J Gastroenterol VL - 46 UR - https://doi.org/10.3109/00365521.2010.537684 DO - 10.3109/00365521.2010.537684 ID - Juul-Hansen2011 ER - TY - JOUR AU - Lodrup, A. B. AU - Reimer, C. AU - Bytzer, P. PY - 2013 DA - 2013// TI - Systematic review: symptoms of rebound acid hypersecretion following proton pump inhibitor treatment JO - Scand J Gastroenterol VL - 48 UR - https://doi.org/10.3109/00365521.2012.746395 DO - 10.3109/00365521.2012.746395 ID - Lodrup2013 ER -